Adma Biologics (ADMA) FCF Margin Growth (3y) (2016 - 2025)
Adma Biologics (ADMA) FCF Margin Growth (3y) (2016 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | -1,272.00 |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | -2,228.00 |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 9,545.00 |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -7.75 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | -3,088.00 |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 4,612.00 |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 14,060.00 |
| 10 | Adma Biologics | 2.13 Bn | 2.00 Bn | 86.28 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 4,709.00 |
| Sep 30, 2025 | 3,976.00 |
| Jun 30, 2025 | 3,770.00 |
| Mar 31, 2025 | 7,792.00 |
| Dec 31, 2024 | 10,790.00 |
| Sep 30, 2024 | 9,834.00 |
| Jun 30, 2024 | 24,669.00 |
| Mar 31, 2024 | 21,750.00 |
| Dec 31, 2023 | 27,884.00 |
| Sep 30, 2023 | 27,039.00 |
| Jun 30, 2023 | 31,531.00 |
| Mar 31, 2023 | 23,270.00 |
| Dec 31, 2022 | 15,477.00 |
| Sep 30, 2022 | 31,392.00 |
| Jun 30, 2022 | 24,563.00 |
| Mar 31, 2022 | 30,888.00 |
| Dec 31, 2021 | 41,595.00 |
| Sep 30, 2021 | 22,362.00 |
| Jun 30, 2021 | 12,735.00 |
| Mar 31, 2021 | 20,084.00 |